z-logo
open-access-imgOpen Access
Allopurinol Use Yields Potentially Beneficial Effects on Inflammatory Indices in Those With Recent Ischemic Stroke
Author(s) -
Scott Muir,
Craig Harrow,
Jesse Dawson,
Kennedy R. Lees,
Christopher J. Weir,
Naveed Sattar,
Matthew R. Walters
Publication year - 2008
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.108.519793
Subject(s) - allopurinol , medicine , uric acid , placebo , tolerability , stroke (engine) , xanthine oxidase , hyperuricemia , gastroenterology , pharmacology , anesthesia , surgery , adverse effect , pathology , biochemistry , mechanical engineering , chemistry , alternative medicine , engineering , enzyme
Elevated serum uric acid level is associated with poor outcome and increased risk of recurrent events after stroke. The xanthine oxidase inhibitor allopurinol lowers uric acid but also attenuates expression of inflammatory adhesion molecules in murine models, reduces oxidative stress in the vasculature, and improves endothelial function. We sought to investigate whether allopurinol alters expression of inflammatory markers after acute ischemic stroke.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom